This report is being filed to provide additional information in h.6 and h.10.Corrected information is provided in b.3.Investigation: the set in question was not returned for investigation and the lot number concerned was unknown.We therefore conducted the following investigation based on the information provided.In making the blood bags concerned, sealed bags are filled with solution and the line is assembled.These bags are sterilized, stacked, and placed into the blister packs.The top film of each blister pack is heat-sealed.In making leukocyte reduction filters, filter membranes are formed and put in filter housings.The lot number was not specified and we therefore reviewed the manufacturing record for the past five years.We confirmed that machine/equipment trouble which could cause the event had occurred.No abnormalities occurred in any processes, and production was carried out as usual.Blood bags are tested on a sample basis for every lot.Various tests including a visual inspection, the volume measurement of blood preservative solution, and the quantitative test for the composition of the solution, are tested and only the lots that have passed the tests are released.The lot number was not specified and we reviewed the testing and inspection record for the past five years.No abnormalities were observed.Root cause: as the above-mentioned investigation results, the manufacturing record and the testing and inspection record of the past five years did not show any abnormalities that could cause the reported issue; therefore, we were not able to identify the cause of the reported issue.
|